Site-Specific Protein Modification via Histidine-Enhanced N-Terminal Reactivity

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for site-specific modification of proteins or peptides are often non-specific, requiring engineering or unnatural amino acids, and the repertoire of selective chemical reactions is limited, making selective derivatization at the N-terminus challenging.

Innovation Solution

A method involving the introduction of a histidine amino acid adjacent to the N-terminus of a protein or peptide, followed by acylation with a specific acylating compound at a pH lower than 6, to facilitate selective modification at the N-terminal amino group.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If classic non-specific labeling methods are used, then the modification process is simple, but the specificity and selectivity of N-terminal modification is poor

Engineering Contradiction:
Improvespecificity of N-terminal modificationVSAvoidcomplexity of modification method
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

The patent introduces a histidine residue at a specific position adjacent to the N-terminus to create a localized reactive site. This local modification (adding one specific amino acid) enables site-specific acylation at the N-terminal amino group while leaving the rest of the protein unchanged, thus achieving high specificity without requiring complex global engineering of the protein structure

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The patent exploits the pH-dependent reactivity difference between the N-terminal amino group and the histidine imidazole group. By conducting the acylation reaction at pH < 6, the N-terminal amino group (pKa ~8-9) remains protonated and reactive, while the histidine imidazole group (pKa ~6.0) is less reactive. This parameter change (pH control) enables selective modification at the N-terminus

Inventive Principle:
Principle #35Parameter changes

2Manufacturing precision

If site-specific modification methods with high selectivity are used, then the specificity improves, but the reaction conditions become more restrictive

Engineering Contradiction:
Improveselectivity of derivatizationVSAvoidflexibility of reaction conditions
Core Design Contradiction:
Manufacturing precisionVSAdaptability or versatility

Solution Approach 1:

The patent achieves selectivity through pH control rather than requiring extreme or specialized conditions. The method works at mildly acidic pH values (< 6), which are compatible with most protein stability requirements. This approach maintains protein folding and activity while enabling selective N-terminal modification, thus balancing selectivity with reaction versatility

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The histidine residue acts as a chemical intermediary that facilitates selective N-terminal modification. The histidine imidazole group has pKa properties that allow it to remain largely unreactive toward acylating agents at pH < 6, while the N-terminal amino group remains reactive. This intermediary approach enables selective derivatization under relatively flexible and mild conditions

Inventive Principle:
Principle #24Intermediary (Mediator)

3Productivity

If the reactivity of N-terminal amino group is increased for better conjugation, then the conjugation efficiency improves, but the risk of non-specific labeling increases

Engineering Contradiction:
Improveconjugation efficiencyVSAvoidspecificity of labeling
Core Design Contradiction:
ProductivityVSManufacturing precision

Solution Approach 1:

The patent creates a localized chemical environment at the N-terminus by introducing a histidine residue. This local structural feature (the XH- motif where X is any amino acid and H is histidine) concentrates the reactivity control function at a specific location, enabling efficient conjugation at the N-terminus while preventing reaction at other sites through the pH-dependent selectivity mechanism

Inventive Principle:
Principle #3Local quality

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables selective and controlled modification of proteins or peptides at the N-terminus, enhancing the reactivity of the N-terminal amino functionality for conjugation with biointeractive or analytical agents, thereby improving specificity and efficiency in protein modification.

Implementation Method 1

using the presence of a neighboring histidine amino acid to increase the reactivity of the N-terminal amino functionality

Methodology Applied
Scientific EffectNeighboring group participation:

Implementation Method 2

contacting the protein or peptide containing a histidine amino acid at the position adjacent to the N-terminus amino acid with an acylating compound at a pH lower than 6, to form a modified protein or polypeptide

Methodology Applied
Scientific EffectAcylation reaction: Chemical Bonding

Data Source

PatentEP3157942B1Site specific protein modifications
Publication Date: 2020.06.17 NOVARTIS AG
  • EP3157942B1 patent drawing
  • EP3157942B1 patent drawing
  • EP3157942B1 patent drawing

AI summary

The present invention relates to method and reagents for use in site-selective modification of protein and peptide. The site selective modification is a selective derivation of the amino functionality at the N-terminus of the protein or the polypeptide using the presence of a neighboring histidine amino acid to increase the reactivity of the N-terminal amino functionality. The modified proteins or peptides obtained by method of the invention may be used for imaging study or therapeutic uses.